Health & Medicinearticle2026-10-22

Predictors of HIV reservoir size and decay dynamics in early-treated paediatric infection: a prospective, multicentre longitudinal cohort study

Open access0 citations

Abstract

Background Early antiretroviral therapy (ART) after perinatal HIV infection can restrict reservoir size and diversity, offering potential for remission. We evaluated HIV-1 DNA dynamics up to four years of age and predictors of reservoir size in early-treated African children. Methods In this prospective, multicentre cohort study, infants with perinatal HIV from South Africa, Mozambique, and Mali who initiated ART before 6 months of age and within 3 months of diagnosis were enrolled. Children were followed at 2, 6, 12, and 24 weeks, then biannually for 4 years. Total HIV-1 DNA in PBMCs was quantified longitudinally by droplet digital PCR in 207 children. The main outcomes were HIV-1 DNA reservoir size at year 3 (log 10 copies/million PBMC) and longitudinal HIV-1 DNA decay. Multivariable models were developed to identify predictors of reservoir size using generalised additive regression models, and decay dynamics were evaluated using mixed-effects Poisson models including random intercepts and viral load slopes. Findings Of 207 children, 155 (75%) had >12 months of follow-up. HIV was diagnosed at a median age of 31 days (IQR: 0, 47) and ART started at 33 days (IQR: 23.5, 69.5). Nineteen of 155 (12.3%) had undetectable HIV-1 DNA at year 4. Median decay rate was −0.020 log10 copies/million cells/month (−0.212/year). Smaller reservoirs at year 3 were associated with lower pre-ART viral load (β = 0.26, 95% CI: 0.09, 0.43) and faster first-year HIV-1 DNA decay rate (β = 1.09, 95% CI: 0.02, 2.19), with trends toward smaller reservoirs among females (β = −0.41, 95% CI: −0.87, 0.04) and larger reservoirs among children whose mothers reported social challenges (β = 0.42, 95% CI: −0.04, 0.87). Faster decay correlated with longer time on ART, lower serial viral loads, sustained viral suppression >12 months, earlier ART initiation, and region (Mali). Maternal health issues correlated with slower decay. Eleven "excellent controllers" maintained durable viral suppression, immunological control, and undetectable total HIV-1 DNA at last follow-up. Interpretation Early virological parameters may help identify children likely to develop smaller HIV reservoirs. Early ART is key to faster reservoir reduction. Maternal health issues influence reservoir decay, reflecting a parental legacy effect. Sex differences should be further explored to understand mechanisms of reservoir control. Children with sustained virological suppression, preserved immune status, and undetectable total HIV-1 DNA may represent candidates with favourable characteristics for HIV remission strategies, as these factors have been associated with a reduced burden of persistent HIV infection and have been observed in rare cases of post-treatment control. Funding EPIICAL consortium through ViiV Healthcare and Penta Foundation.

// Source

View paper (DOI)Open access versionOpenAlexEBioMedicinePublished 2026-10-22

Authors: Kavidha Reddy, Sara Domínguez‐Rodríguez, Chantal Molechan, Mark Cotton, Kennedy Otwombe, Maria Grazia Lain, Tacilta Nhampossa, Almoustapha Issiaka Maiga, Shaun Barnabas, Paula Vaz, Avy Violari, Sheila Fernández-Luis, Ngundu Osee Behuhuma, Mariam Sylla, Afaaf Liberty, Theresa Smit, Gregory Ording-Jespersen, Nália Ismael, Carlo Giaquinto, Paolo Rossi, Louise Kuhn, Paolo Palma, Nicola Cotugno, Moira J. Spyer, Alvaro Ballesteros Magán, Andrea Oletto, Els Dobbels, Pablo Rojo, Thumbi Ndung’u, Alfredo Tagarro, Viviana Giannuzzi, Anita Janse Van Rensburg, Yasmeen Akhalwaya, Nigel Klein, Nastasja Ramsagar, Senamile Makhari, Elisa López, Denise Naniche, Yacouba Aba Coulibaly, Caroline Foster, Helena Rabie, Pauline Amugue, Camille Bréhin, Savita Pahwa, Elena Morrocchi, Eleni Nastouli, Fatoumata Tata, Matthias Lichterfeld, Loide Cardoso, Rizaam Meyer, Moherndran Archary, Oumar Dolo, Josué Togo, Kurt Smith, Mornay Isaacs, Ligia Estevao

Institutions: University of Padua, Harvard University, University of the Witwatersrand, University College London, Universidad Complutense de Madrid, Barcelona Institute for Global Health, Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology, Research Institute Hospital 12 de Octubre, Hospital Universitario 12 De Octubre, Universitat de Barcelona, Columbia University Irving Medical Center, University of KwaZulu-Natal, Africa Health Research Institute, Stellenbosch University, University of Rome Tor Vergata, Universidad Europea de Madrid, Bambino Gesù Children's Hospital, Instituto Nacional de Saúde, Manhiça Health Research Centre, Hospital Universitario Infanta Sofía, Tygerberg Hospital, Fundação Ariel Glaser Contra o SIDA Pediátrico, PENTA Foundation, Hospital Universitario del Henares, Perinatal HIV Research Unit